Condition

Neurodegenerative Disorders

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 7 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials7
Recruiting2
Common interventions4
Lead sponsors shown7
Advertisement

Clinical trials

7 shown
Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute ConditionsNCT04684602 · 2020-07-09
RECRUITING
Development of IPS from Donated Somatic Cells of Patients with Neurological DiseasesNCT00874783 · 2009-04-01
RECRUITING
An Innovative Method in SAliva Samples for the Early Differential Diagnosis of High-impact NeuroDegenerative Diseases Through Raman SpectroscopyNCT06875739 · 2025-02-14
ENROLLING_BY_INVITATION
Exploratory Clinical Study and Validation of Blood Biomarkers for Alzheimer's DiseaseNCT07294586 · 2019-10-28
COMPLETED
Bilateral Pallidal Stimulation in Patients With Advanced Parkinson's Disease-LATESTIMNCT02823158 · 2016-09-01
TERMINATED
COMPARATIVE EFFECTIVENESS OF MCI and DEMENTIA TREATMENTS IN A COMMUNITY-BASED DEMENTIA PRACTICENCT02860338 · 2009-01-01
COMPLETED
Clinical and Genetic Study of Neurodegenerative Disorders With Cognitive ImpairmentNCT00149175 · 2002-12-01
COMPLETED

Trial status mix

COMPLETED3
RECRUITING2
ENROLLING_BY_INVITATION1
TERMINATED1

Phase mix

NA1
PHASE11
PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.